Results 101 to 110 of about 5,401 (225)

Granulomatous periorificial dermatitis in an adult: A rare case report

Journal of Dr. NTR University of Health Sciences, 2018
Granulomatous periorificial dermatitis (GPD) is a distinctive form of perioral dermatitis. It is a condition of unknown etiology, characterized by monomorphic, small, papular eruptions around the mouth, nose, and eyes, and granulomatous pattern on ...
Sudharani Chintagunta, Srinivas Manchala, Geetakiran Arakkal   +2 more
doaj   +1 more source

No significant association between malignancy and topical use of pimecrolimus

JAMA dermatology, 2015
Importance A black box warning describes a potential risk of malignancy associated with the topical use of pimecrolimus to treat atopic dermatitis (AD) due to its similarity to oral calcineurin inhibitors used in solid organ transplantation and ...
D. Margolis, K. Abuabara, O. Hoffstad, J. Wan, D. Raimondo, W. Bilker   +5 more
semanticscholar   +1 more source

Observation on the clinical efficacy of delicate pulsed light combined with 1% pimecrolimus cream in the treatment of erythema telangiectasia rosacea

Pifu-xingbing zhenliaoxue zazhi
Objective To investigate the clinical efficacy and safety of delicate pulsed light combined with 1% pimecrolimus cream for erythema telangiectasia rosacea.
HU Xueying, HU Lingwei
doaj   +1 more source

Analysis of reduction in IGA (Pimecrolimus vs vehicle).

, 2014
Analysis of reduction in IGA (Pimecrolimus vs vehicle).
Youyu Sheng (545451), Chunyun Huang (545450)   +1 more
core   +1 more source

Pimecrolimus cream in repigmentation of vitiligo [PDF]

, 2007
Background: Vitiligo is a chronic disease that mostly affects children and young adults. Nowadays many treatment options are available; however, most of them have limited efficacy and in most cases would result in undesirable complications. Objective: To
Farnaghi, F., Alirezaie, N.-S., Firooz, A., Seirafi, H., Vasheghani-Farahani, A., Dowlati, Y.   +5 more
core  

Pimecrolimus Efficacy and Safety in Management of Children with Atopic Dermatitis

Вопросы современной педиатрии
Atopic dermatitis (AD) is one of the most common inflammatory skin diseases. Early management of AD is crucial for preventing the development of atopic disease such as asthma, allergic rhinitis, etc.
Nikolay N. Murashkin, Ekaterina S. Pavlova, Roman V. Epishev, Alexander I. Materikin, Roman A. Ivanov, Leonid A. Opryatin, Dmitriy V. Fedorov, Mariya A. Leonova, Alena A. Savelova   +8 more
doaj   +1 more source

Comparison of the Efficacy of Topical Tacrolimus, Pimecrolimus, Methylprednisolone Aceponate and Narrow Band UVB in the Treatment of Vitiligo

, 2018
Background: The treatment of vitiligo is currently very difficult. Aims: The aim of the present study was to determine the efficacy and safety of narrow-band UVB (NB-UVB), topical pimecrolimus, topical tacrolimus and topical methylprednisolone aceponate ...
D. Sb
semanticscholar   +1 more source

A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation – JOELLE study)

Clinical Epidemiology, 2018
Jordi Castellsague,1 Josephina G Kuiper,2 Anton Pottegård,3 Ingegärd Anveden Berglind,4 Daniel Dedman,5 Lia Gutierrez,1 Brian Calingaert,6 Myrthe PP van Herk-Sukel,2 Jesper Hallas,3 Anders Sundström,4 Arlene M Gallagher,5 James A Kaye,7 ...
Castellsague J, Kuiper JG, Pottegård A, Anveden Berglind I, Dedman D, Gutierrez L, Calingaert B, van Herk-Sukel MP, Hallas J, Sundström A, Gallagher AM, Kaye JA, Pardo C, Rothman KJ, Perez-Gutthann S   +14 more
doaj  

Successful Treatment of Cutaneous Lesions of Dermatomyositis with Topical Pimecrolimus

, 2011
Dermatomyositis (DM) is an idiopathic inflammatory process characterized by proximal muscle weakness and cutaneous lesions, such as the Gottron's sign, heliotrope rash, and erythematous photosensitive. rash.
Myeong Gil Jeong, Ji Eun Kim, Joo Yeon Ko, Ha Eun Lee, Young Suck Ro, ���������   +5 more
core   +1 more source

Low systemic exposure after repeated topical application of Pimecrolimus (Elidel), SD Z ASM 981) in patients with atopic dermatitis

, 2002
BACKGROUND: Pimecrolimus is a cell-selective inhibitor of inflammatory cytokine release developed specifically for the treatment of inflammatory skin diseases.
van Leent, Edwin J. M., Dorobek, Birgit, Spuls, Phyllis I., Bos, Jan D., Ebelin, Marie Eve, Burtin, Pascale   +5 more
core   +1 more source